Berkeley Lights, Inc. (BLI)
Stock analysis · NASDAQ · Healthcare · Biotechnology
Berkeley Lights, Inc. (BLI) is a publicly traded company in the Healthcare sector. Latest price: $1.20. Market cap $86.61M. Trailing PE -0.85. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Earnings
Proprietary Signals
About Berkeley Lights, Inc.
Berkeley Lights, Inc. (BLI) is a digital cell biology firm dedicated to empowering and expediting the advancement and market introduction of biotherapeutic and other cell-based products. The company provides a unified technology platform, which encompasses proprietary consumables such as OptoSelect chips and specialized reagent kits, sophisticated automation systems, and purpose-built application and workflow software. BLI extends its services to clients across North America, the Asia Pacific region, and Europe. Founded in 2011, its corporate headquarters are located in Emeryville, California.
Valuation
| P/E (TTM) | -0.85× |
|---|---|
| P/S (TTM) | 1.10× |
| P/B | 0.58× |
| PEG | 0.04× |
| P/FCF (TTM) | -1.56× |
| EV / EBITDA | -0.52× |
| EV / Sales | 0.54× |
| Earnings Yield | -118.63% |
| Free Cash Flow Yield | -64.21% |
Fundamentals
| Enterprise Value | $42.64M |
|---|---|
| Revenue (TTM) | $78.59M |
| Net Income (TTM) | -$102.75M |
| Free Cash Flow (TTM) | -$54.70M |
| Net Debt | -$43.97M |
| Working Capital | $131.46M |
| Gross Margin | 68.43% |
| Operating Margin | -120.29% |
| Net Margin | -124.74% |
| Return on Equity | -55.98% |
| Return on Invested Capital | -50.95% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap